Takeaway
Distinctive clinical features in people with amyotrophic lateral sclerosis (ALS) are associated with differential myeloid cell signatures.
Why this matters
A problematic aspect of ALS research is its heterogeneous nature; the ability to identify cell populations and markers may lead to targeted mechanistic studies and immunomodulation therapy development.